Skip to main content

Table 1 Characteristics of study population

From: Prevalence of arterial stiffness in North China, and associations with risk factors of cardiovascular disease: a community-based study

 

Healthy sample

Overall sample

male

female

male

female

N

342

859

1275

1577

Age , years

46.2 ± 15.4

46.7 ± 13.8

52.5 ± 12.7

54.0 ± 14.9

BaPWV, cm/s

1339.3 ± 224.8

1294.8 ± 241.9

1524.8 ± 355.7

1578.6 ± 463.6

BMI, kg/m 2

23.8 ± 2.9

22.8 ± 2.9

24.7 ± 3.2

23.9 ± 3.4

MAP, mmHg

89.8 ± 7.3

85.3 ± 8.8

97.9 ± 18.8

94.7 ± 13.3

SBP, mmHg

123.9 ± 13.2

120.6 ± 12.1

131.8 ± 17.9

130.9 ± 20.9

DBP, mmHg

74.4 ± 7.5

70.2 ± 8.4

80.9 ± 24.1

76.6 ± 10.9

Pulse pressure, mmHg

46.0 ± 7.9

45.3 ± 9.1

50.9 ± 24.9

54.5 ± 14.9

HR, beats/min

70.8 ± 9.4

71.4 ± 9.4

70.9 ± 10.2

71.6 ± 10.1

TC, mmol/L

4.57 ± 0.81

4.75 ± 0.94

4.73 ± 0.94

5.09 ± 1.06

HDL-C, mmol/L

1.37 ± 0.29

1.44 ± 0.33

1.29 ± 0.29

1.39 ± 0.33

LDL-C, mmol/L

2.67 ± 0.62

2.75 ± 0.83

2.81 ± 0.76

3.02 ± 0.91

TG, mmol/L

1.53 ± 1.04

1.31 ± 0.87

1.80 ± 1.27

1.59 ± 0.99

Fasting glucose, mmol/L

4.9 ± 0.6

4.9 ± 0.5

5.4 ± 1.4

5.4 ± 1.6

Hypertension, %

0

0

50.3

47.8

Diabetes, %

0

0

23.7

21.1

Smoking, %

0

0

50.2

3.7

Stroke, %

0

0

7.2%

6.5%

Ischemic heart disease, %

0

0

10.9

7.1

Medication

    

ACEIs/ARBs, %

0

0

9.9

8.9

Statins, %

0

0

6.6

4.9

CCBs, %

0

0

15.3

14.5

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP Mean arterial pressure; BaPWV Brachial-ankle pulse wave velocity, CCBs Calcium channel blockers, ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin receptor blockers, HR heart rate, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, TG triglyceride.